Remicade gains preliminary European approval
Government says animal research must go ahead
Studies not putting women off HRT
Litigation only option for Biota
Roche positive about Tarceva
Exanta to be a big hit for AstraZeneca
E55.3 billion to create new number three
Opponents question dose level
BM to raise Velcade's awareness
PCTs handed massive financial agenda